The Food and Drug Administration recently ordered artificial hip manufacturers to undertake studies of their implants, and manufacturers of metal-on-metal hip devices will have to conduct studies of patients who received the device to determine whether the implants are shedding…
The Latest
A multidisciplinary approach to treating and preventing deep surgical site infections for orthopedic patients can reduce the common SSIs among joint replacement surgeries, according to a Medscape Medical News report.
OrthoIndy physicians successfully maintain an alignment with St. Vincent Health in Indianapolis for a strategic partnership between the two groups. The partnership allows OrthoIndy physicians to maintain autonomy but still partner with the hospital to navigate the healthcare world more…
Using three dimensional bioprinting technology, scientists have been able to print skin and vertebral discs and implant them into non-human bodies successfully, according to a story published in The Washington Post.
MetroHealth, a northwest Ohio health system, recently brought orthopedic spine surgeons and neurosurgeons together to create a new department of neurosciences, according to a system news release.
Post-traumatic stress disorder occurs in 20-51 percent of patients who experience a traumatic orthopedic injury, according to a study published in the Journal of the American Academy of Orthopaedic Surgeons.
The Food and Drug Administration issued 13 spine device-related 510(k) clearances in April, according to an FDA report.
Over the last two years, Palos Surgicenter in Palos Heights, Ill., has helped his center almost triple orthopedic case volume with the help of Administrator Thomas Holecek. He discusses seven points on significantly increasing orthopedic case volume in surgery centers.
Polymethylmethacrylate augmentation provides an increased resistance to cyclic loading when compared to calcium triglyceride bone cement for augmenting the sacral screw fixation, according to a study published in Spine.
BioMimetic Therapeutics, a biotechnology company focused on developing products to heal musculoskeletal injuries and diseases, recently reported a net loss of $8 million, ending the first quarter of 2011 with $83.7 million in cash, cash equivalents and investments, according to…